A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Condition:   Acute Myeloid Leukemia and Myelodysplastic Syndrome Intervention:   Drug: QLF32101 Sponsor:   Qilu Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials

Clinical Efficacy and Mechanism of Yisui Granule in Treatment of Low and Medium Risk Myelodysplastic Syndrome Through Demethylation
Condition:   MDS Interventions:   Drug: Yisui granule;   Drug: Placebo Sponsor:   Dongzhimen Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2023 Category: Research Source Type: clinical trials